Elsevier Expands ClinicalKey AI with JAMA Network Content Deal
Event summary
- Elsevier has signed a strategic content agreement with the JAMA Network to integrate full-text content and visuals from 13 JAMA journals into ClinicalKey AI.
- The deal provides clinicians access to more than half of the world's top 100 medical journals through ClinicalKey AI.
- ClinicalKey AI is designed to deliver evidence-based answers with direct links to full-text articles, enhancing clinical decision-making.
- The agreement emphasizes trust, privacy, and security in AI-driven clinical solutions.
- Content from the JAMA Network journals is now available to ClinicalKey AI customers.
The big picture
This agreement underscores the growing importance of AI-driven clinical decision support tools in healthcare. By leveraging high-quality, evidence-based content from the JAMA Network, Elsevier is positioning ClinicalKey AI as a critical resource for clinicians navigating the complexities of modern medical practice. The deal also highlights the strategic value of content partnerships in differentiating AI solutions in a competitive market.
What we're watching
- AI Adoption
- How the integration of JAMA Network content will accelerate clinician trust and adoption of ClinicalKey AI at the point of care.
- Data Integration
- The pace at which Elsevier can deliver deeper integration with electronic health records following the WellSheet acquisition.
- Market Positioning
- Whether Elsevier can sustain its leadership in clinical AI solutions amid increasing competition in the healthcare information sector.
